ORIFARM PI A/S: Financial statements 2024
CVR: 27347177
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -58,000 and a net result of DKK 320,939,000 compared with DKK 253,407,000 the year before. Equity in the 2024 report amounted to DKK 1,161,019,000. The solvency ratio was 87.3%.
- Gross Profit
- DKK -58,000
- Profit/Loss
- DKK 320,939,000
- Equity
- DKK 1,161,019,000
- Total Assets
- DKK 1,330,336,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -58K | 320.9M | 1.2B | 0 |
| 2023 | - | -95K | 253.4M | 940.7M | - |
| 2022 | - | -73K | 182.9M | 687.4M | 0 |
| 2021 | - | -76K | 206M | 760M | 0 |
| 2020 | - | -57K | 208.7M | 563.8M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ORIFARM PI A/S has published its annual report for 2023. Gross profit came to DKK -95,000, and the net result was DKK 253,407,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.